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Abstract: Highly porous bioceramics, based on a complex hardystonite solid solution, were developed
from silicone resins and micro-sized oxide fillers fired in air at 950 ◦C. Besides CaO, SrO, MgO, and ZnO
precursors, and the commercial embedded silicone resins, calcium borate was essential in providing
the liquid phase upon firing and favouring the formation of an unprecedented hardystonite solid
solution, corresponding to the formula (Ca0.70Sr0.30)2(Zn0.72Mg0.15Si0.13) (Si0.85B0.15)2O7. Silicone-filler
mixtures could be used in the form of thick pastes for direct ink writing of reticulated scaffolds or for
direct foaming. The latter shaping option benefited from the use of hydrated calcium borate, which
underwent dehydration, with water vapour release, at a low temperature (420 ◦C). Both scaffolds
and foams confirmed the already-obtained phase assemblage, after firing, and exhibited remarkable
strength-to-density ratios. Finally, preliminary cell tests excluded any cytotoxicity that could be
derived from the formation of a boro-silicate glassy phase.
Keywords: polymer derived ceramics (PDCs); biosilicate ceramics; hardystonite; foams; 3D printed
scaffolds; direct ink writing (DIW)
1. Introduction
Silicone polymers, homogeneously mixed with oxide fillers, have been extensively investigated
as precursors for silicate bioceramics for the last ten years [1]. A fundamental advantage in all
polymer-derived ceramics concerns the possible application of polymer forming techniques, both
conventional (e.g., foaming) and advanced (e.g., additive manufacturing technologies), so that a
component is first shaped at low temperature and then ‘ceramised’ [2]. Ideally, the ceramic conversion
implies just a homogeneous shrinkage, with no microcracking; in actual polymer-derived components,
if not thin-walled (e.g., films, fibres, foams) [2], the structural integrity is favoured by the adoption
of fillers (either ‘passive’, i.e., simply ‘diluting’ the mass of polymer undergoing transformation, or
‘active’, when fillers react with the matrix and/or with the firing atmosphere) [3–5].
In the case of silicates, an additional advantage is the high reactivity of amorphous silica,
which results from the ceramic conversion of silicones in air. When mixed with additional oxides,
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polymer-derived silica leads to highly phase-pure crystalline materials at low temperatures [1]. This
reaction obviously occurs once silicone/fillers weight ratios match the expected silica/metal oxide
balance of the desired silicates, considering the weight losses in both ceramic conversion of silicones
and transformation of fillers (dehydration of hydroxides, decarbonation of carbonates, etc.), operating
with fillers of adequate granulometry and phase composition. Nano-sized fillers are generally more
reactive and the same oxide, e.g., alumina, may react well in one specific polymorphic form, γ-Al2O3,
instead of another, α-Al2O3 [1].
Oxide fillers do not simply provide reactants for the amorphous silica matrix. The same
transformation of fillers (e.g., dehydration of Mg(OH)2 into MgO [6]) may occur below the onset of
ceramic conversion of the matrix, leading to some gas release, which, in turn, is exploited for foaming.
In other words, fillers may contribute to the chemistry and the shaping of silicate ceramics. In addition,
selected fillers (borates, phosphates) [6,7] provide a liquid phase upon firing, enhancing the ionic
interdiffusion (diffusion is easier in liquid than in solids) and enabling the development of phase-pure
silicates even from coarser fillers. As an example, phase-pure akermanite, Ca2MgSi2O7, was developed
from silicone-based mixtures, involving CaCO3, as CaO precursors, in both micro- and nano-sized
powders, when also including Na-borate [6].
Among different polymer-derived biosilicates, hardystonite (Ca2ZnSi2O7) deserves particular
attention. In fact, ceramics based on this phase are currently considered to be very promising
alternatives to bioactive glasses in bone tissue engineering applications. They are known to stimulate
osteogenic differentiation, cell proliferation and differentiation (among mesenchymal stem cells and
bone cells, such as osteoblast-like cells and osteoclasts), and expression of alkaline phosphatase (ALP),
osteocalcin, and collagen type I when in contact with human osteoblast (HOB) cells [8–10]. Additionally,
induction of vascularisation is a crucial part of any successful bone regeneration strategy. In recent
years, in vitro studies have shown that bioactive glasses in biomaterial-based tissue engineering (TE)
applications are capable of stimulating vascularisation [11–13].
Most hardystonite ceramics are derived from the sintering of crystalline powders previously
prepared by the sol-gel method [14–16]. An alternative is derived from the processing of glass powders,
undergoing sintering with concurrent crystallisation [17–19]. While the sintering of ceramic powders
yields phase-pure materials, the glass approach may yield secondary, inert phases (e.g., Zn aluminate)
once the glass formulation does not exactly match that of hardystonite [17].
Previous attempts to create polymer-derived hardystonite were aimed at realising the
above-mentioned distinctive coupling of shaping and synthesis, typical of polymer-derived ceramics,
with the maximum phase purity [20]. All attempts, however, showed some drawbacks. First, the
simplest precursors for CaO and ZnO (CaCO3 and ZnO) could not be used for low temperature
foaming [20]; second, not strictly thin-walled components, such as 3D scaffolds from direct ink writing
of silicone-reactive fillers pastes, were severely microcracked if they did not contain pre-synthesised
hardystonite powders as extra, passive filler [21]. An opportunity for low-temperature foaming
and some relaxation of stresses developed upon firing (by ceramic conversion and crystallisation of
hardystonite) were provided by the adoption of Ca-borate (colemanite) in both hydrated (2CaO 3B2O3
5H2O) and anhydrous (2CaO 3B2O3) forms [22].
Besides Ca2+ ions, B3+ ions, from calcium borate, may also be incorporated in hardystonite-based
solid solutions. In fact, hardystonite belongs to the vast group of melilites, i.e., minerals with a
distinctive layered structure, offering many possibilities for ionic exchange [22]. Combinations of Zn2+
and Si4+ ions (in ZnSi2O74− sheets, sandwiching Ca2+ ions) could be replaced by combinations of
Si4+ and B3+ ions (forming SiB2O74− sheets in okayamalite, a B-containing melilite [23]) in tetrahedral
coordination. Although successful in providing strong, crack-free foams and scaffolds, the introduction
of calcium borate did not lead to phase purity [22]. Additional attempts were dedicated to the inclusion
of Sr2+ (replacing Ca2+) and Mg2+ (replacing Mg2+) [24]; bioactive ceramics featuring a complex
hardystonite solid solution were effectively achieved, but again with limitations on direct processing
(glass had to be used as additional filler to enhance the interdiffusion).
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The present papers aimed to highlight the conditions for the direct fabrication of highly-porous
ceramics from silicone polymers and several oxide fillers, based on a complex hardystonite solid
solution, such as (Ca0.70Sr0.30)2(Zn0.72Mg0.15Si0.13) (Si0.85B0.15)2O7. This solid solution is interesting,
since it couples the hardystonite structure with the simultaneous doping of Sr, Mg, and B ions, known
to enhance the functionalities of silicate bioceramics [17,25–30]. In particular, the presence of boron is
interesting, given its biological activity in terms of osteogenesis and angiogenesis [31]. The obtained
ceramics were subjected to a detailed mineralogical analysis as well as to cell tests to assess whether
any cytotoxic effect could arise, as an example, from part of the B2O3 left in the residual glass phase.
2. Materials and Methods
2.1. Formulation of Batches for Hardystonite Solid Solutions
The initial reference consisted of 75 mol% hardystonite (Ca2ZnSi2O7) and 25 mol% okayamalite
(Ca2SiB2O7), theoretically expressed as Ca2Zn0.75B0.5Si1.75O7 [22]. We considered the exchange of
Ca2+ ions (octahedral sites) and Zn2+ ions (tetrahedral sites) with Sr2+ and Mg2+, respectively. The
overall chemical formula was Ca2−xSrxZn0.75−yMgyB0.5Si1.75O7, with x and y representing the degree
of substitution, from 0 up to 30 at%. The batch formulations are reported in Table 1.
Table 1. Formulations adopted with relative number of substituted ions and chemical formula.
Sample
Type
Chemical Formula
Batch Formulation for 100 g Ceramic Yield
MK Silicone
(g) CaCO3 (g) ZnO (g)
Colemanite
(Ca2B6O11) (g)
SrCO3 (g) MgO (g)
X15 Ca1.7Sr0.3Zn0.75B0.5Si1.75O7 42.3 51.93 20.6 9.1 14.99 0
X30 Ca1.4Sr0.6Zn0.75B0.5Si1.75O7 42.3 41.76 20.6 9.1 29.99 0
Y15 Ca2Zn0.64Mg0.11B0.5Si1.75O7 42.3 62.1 17.51 9.1 0 1.53
Y30 Ca2Zn0.53Mg0.22B0.5Si1.75O7 42.3 62.1 14.42 9.1 0 3.06
X30Y15 Ca1.4Sr0.6Zn0.64Mg0.11B0.5Si1.75O7 42.3 41.76 17.52 9.1 29.99 1.53
X30Y30 Ca1.4Sr0.6Zn0.53Mg0.22B0.5Si1.75O7 42.3 41.76 14.42 9.1 29.99 3.06
The mixtures were calculated according to the silica yield (84 wt%) [1] of the first adopted
commercial silicone (MK, Wacker-Chemie GmbH, Munich, Germany). The reactive fillers consisted of
commercially available powders, such as CaCO3 (<10 µm, Industrie Bitossi, Vinci, Italy), ZnO (<1.48
µm, Sigma Aldrich, Germany), colemanite (Ca2B6O11·5 H2O, <1 µm, supplied by CIRCe, University of
Padua, Padua, Italy, used after dehydration, by calcination at 500 ◦C), MgO (30 nm, Inframat Advanced
Materials LLC, Manchester, CT, USA), and SrCO3 (<10 µm, Bitossi, Italy).
MK was first dissolved in isopropyl alcohol under magnetic stirring. Clear solutions were then
added with the fillers (powders were slowly cast in the MK solutions), again under magnetic stirring,
for 15 min. After sonication for 15 min, the mixtures were left to dry at 80 ◦C overnight in Teflon
containers. Finally, dried powders were dry ball milled (Pulverisette 7 planetary ball mill, Fritsch,
Idar-Oberstein, Germany), sieved below 90 µm, and pressed in a cylindrical die (diameter of 16.5 mm)
at 40 MPa.
A second series of samples, with the same overall formulation (X30Y15, i.e.,
Ca1.4Sr0.6Zn0.64Mg0.11B0.5Si1.75O7), was prepared by replacing MK with H62C silicone (MK,
Wacker-Chemie GmbH, Munich, Germany), colloidal silica (SiO2, Aerosil R106, Evonik, Germany; 10
wt% of total silica), and quartz sand (<100 µm, Industrie Bitossi, Vinci, Italy). As reported in Table 2,
the batches had to be recalculated according to the different silica yield of the silica precursors (58 w%
for H62C [1], 100 wt% for colloidal silica and quartz).
All pressed tablets were fired in air at 950 ◦C, with a 1 h holding time and a heating rate of
2 ◦C/min, followed by natural cooling.
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Table 2. Alternative batches for X30Y15 hardystonite ceramics.
Silica Precursor Type Batch Formulation for 100 g Ceramic Yield
Silica Precursor (g) CaCO3 (g) ZnO (g) Colemanite (g) SrCO3 (g) MgO (g)
H62C 63.4 41.76 17.52 9.1 29.99 1.53
Colloidal silica 35.5 41.76 17.52 9.1 29.99 1.53
Quartz sand 35.5 41.76 17.52 9.1 29.99 1.53
2.2. Direct Ink Writing of Hardystonite Scaffolds
Pastes for direct ink writing experiments were based on MK. As previously done [21], the
viscosity of MK-based pastes was adjusted by using colloidal silica, which replaced MK in an amount
corresponding to 10 wt% of the total silica content. Colloidal silica as well as the other fillers (CaCO3,
ZnO, anhydrous colemanite (Ca2B6O11), MgO and SrCO3) were all added in an MK paste formed by
mixing the silicone with an appropriate solvent (30 vol%). The oxide balance corresponded to X30Y15
and X30Y15B formulations (Table 1). The mixtures were homogenised by ball milling for 5 h at 300 rpm
before printing. The printing process was carried out, in air, through a conical nozzle (with a diameter
of 0.81 mm—Nordson EFD, Westlake, OH, USA), using a Delta printer (Wasp, Massa Lombarda, Italy).
Reticulated structures resulted from the overlapping of filaments of about 0.8 mm diameter, with two
different spacing distances (0.8 and 1.6 mm). After printing, the scaffolds were dried in air overnight.
The ceramisation process was carried out in air at 950 ◦C for 1 h, with a heating rate of 0.3 ◦C/min,
followed by natural cooling. During the heating phase, selected samples underwent an intermediate
holding step at 590 ◦C for 3 h.
2.3. Preparation of Hardystonite Foams
H62C was used, instead of the MK polymer, as a silica source for foams. The formulations followed
those previously shown in Table 1, except for the replacement of MgO with Mg(OH)2 (<10 µm, Industrie
Bitossi, Vinci, Italy) and the use of colemanite in the hydrated form (Ca2B6O11·5H2O). After drying
at 60 ◦C overnight, any H62C-based mixture turned into a viscous paste and was later cast in an
aluminium cylindrical moulds (diameter of ~16 mm). The paste was foamed by direct insertion in a
furnace set at 420 ◦C for 10 min. Once extracted from the furnace, hardened foams were separated
from the aluminium moulds and subjected to a final thermal treatment. Finally, the ceramisation was
performed with the same schedule adopted in the case of the scaffolds.
2.4. Characterisations
The bulk density of foams and scaffolds was determined from the weight-to-volume ratio using a
calliper and a digital balance. The apparent and true densities of these cellular parts were measured
by a gas pycnometer (Helium gas, Micromeritics AccuPyc 1330, Norcross, GA, USA). Morphological
details and microstructural characterisations were achieved by optical stereomicroscopy (AxioCam ERc
5s Microscope Camera, Carl Zeiss Microscopy, New York, NY, USA) and SEM (FEI Quanta 200 ESEM,
Eindhoven, The Netherlands and JSM JEOL 6490 SEM microscope, JEOL, Tokyo, Japan) equipped with
Energy-dispersive X-ray spectroscopy (EDS).
The compressive strengths of hardystonite (HT)-based foams and scaffolds were measured at room
temperature, using an Instron 1121 UTM (Instron, Danvers, MA, USA) operating with a cross-head
speed of 0.5 mm/min. Each data point represents the average value of at least 10 individual tests.
The identification of the crystalline phases was performed on finely ground powders by X-ray
diffraction (XRD; Bruker AXS D8 Advance, Bruker, Karlsruhe, Germany) with the support of the
databases of the crystallographic patterns PDF-2 (ICDD-International Center for Diffraction Data,
Newtown Square, PA, USA), the Match! program (Crystal Impact GbR, Bonn, Germany), and the COD
database (Crystallography Open Database, www.crystallography.net).
Furthermore, a detailed, multi-analytical approach, comprising microstructural, microchemical,
and mineralogical investigations, was applied on pellets the X30Y15 formulation (derived from MK)
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to quantitatively verify the formation of a stable solid solution phase, including Sr2+, Mg2+, and
B3+ ions, in the hardystonite structure. The cross-section of a fired pellet was firstly characterised
by SEM-EDS (CamScan MX2500 SEM, Waterbeach, United Kingdom; EDAX, Mahwah, NJ, USA).
Subsequently, the same pellet was subjected to a quantitative micro-chemical characterisation by
wavelength-dispersive electron microprobe (WDS-EMP; Cameca SX50, CAMECA, Gennevilliers,
France). Forty point analyses were acquired from homogeneous areas of the samples, calculating the
weight percentages of boron oxide by subtraction from the overall sum of recalculated oxides due
to the insensitivity of the instrument to light elements. Then, the mean composition of oxides in the
solid solution was determined and used as the input for the calculation of the experimental crystal
chemical formula. Finally, quantitative phase analysis (QPA) and structural refinement, based on the
Rietveld method [32], were performed on a highly detailed diffraction pattern (14 h data collection with
PANalytical X´Pert PRO, PANalytical, The Netherlands), using HighScore Plus 4.7 program package
(PANalytical, Almelo, The Netherlands).
Eluates of hardystonite scaffolds were subjected to cytotoxicity assessment tests. Therefore, a
suitable bone marrow stromal cell line (ST-2, Deutsche Sammlung für Mikroorganismen und Zellkultur,
Germany), isolated from bone marrow of BC8 mice, was used for this purpose. The cells were
cultured in CMM (RPMI 1640 medium (Gibco, Germany)) containing 10 vol% fetal bovine serum (FBS)
(Sigma-Aldrich, Germany), 1 vol% penicillin/streptomycin (Sigma-Aldrich), and 1 vol% Glutamax
(Gibco)). For these tests, 100,000 ST2 cells were seeded in 1 mL CCM in 24-well plates for 24 h
(incubated at 37 ◦C in a humidified atmosphere of 95% air and 5% CO2). Simultaneously, scaffold
samples were incubated in CCM for 24 h in a ratio 5 g:5 mL. CCM was removed from the samples and
samples were then diluted with CCM to form 1%, 0.1%, and 0.01% dilutions. Finally, these dilutions
were used to cultivate the cells for 48 h (with pure CCM as control). For assessing the influence of
different material supernatant concentrations on the viability of the cultivated cells, a WST-8 assay
(Sigma-Aldrich) was used. The amount of released VEGF from ST-2 cells into the cell culture medium
was measured by using a RayBio Human VEGF ELISA (Enzyme-Linked Immunosorbent Assay) kit. In
order to observe the morphology of the bone marrow stromal cells cultivated with different dilutions
of the of hardystonite scaffolds, H&E (Hematoxylin & Eosin) staining was performed.
3. Results
3.1. Phase Evolution
The starting point for the present investigation consisted of the theoretical solid solution between
Zn- and B-based melilites, such as hardystonite (HSt, Ca2ZnSi2O7) and okayamalite (Ok, Ca2B2SiO7),
as previously studied [22]. Silicone-filler mixtures designed for a stoichiometry 75 mol% HSt–25 mol%
Ok (Ca2Zn0.75B0.5Si1.75O7) did not yield a single phase, forming a solid solution with approximate
stoichiometry of Ca2Zn0.83B0.33Si1.83O7, accompanied by traces of wollastonite (CaSiO3) and calcium
borate [22]. However, the formulation had significant advantages in producing hardystonite in a
single process (no treatment of a previously synthesised powder) at a particularly low temperature
(<1000 ◦C).
The ceramic from formulation X15 confirmed the feasibility of a single process production at
low temperature, but it evidently did not follow the ideal structure (single phase, consisting of
Ca1.7Sr0.3Zn0.75B0.5Si1.75O7), as seen in the diffraction patterns in Figure 1. Most diffraction peaks
matched the ones of pure hardystonite (PDF#35-0745), except for a small downshift in the 2θ positions.
This downshift is reasonable, owing to the Sr doping; Sr hardystonite (Sr2ZrSi2O7) is known to feature
a diffraction pattern similar to that of hardystonite, but with all peaks shifted at lower 2θ positions [26]).
The peak at 2θ~30◦ could be attributed, as in previous studies, to wollastonite (CaSiO3, PDF#10-0489).
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to the X30Y15 formulation obtained (according to the same firing schedule) from two different silicones
and two different forms of silica. One could suppose that using calcium borate which leads to a liquid
phase, could provide a strong ‘fluxing’ action and dissolve most parts of the other components at the
early stages of firing, forming a viscous mass and later crystallising into a hardystonite solid solution.
It was evident that neither quartz sand nor the more reactive colloidal silica led to the expected phase.
Calcium and calcium-magnesium silicates (Ca2SiO4, PDF#31-0298, and CaMgSi2O6, PDF#89-1484)
could be found along with quartz (PDF#86-1560) and ZnO (PDF#89-0511).
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Figure 2. Assessment of reactivity of different silica sources in the development of hardystonite
solid solution.
Amorphous silica from the oxidation of silicone had a confirmed high reactivity towards oxide
fillers. Switching from MK to H62C did not modify the developed phase given the position and the
intensity of diffraction peaks; H62C likely resulted in just a reduction in crystal size, considering the
broadening of diffraction peaks, as seen in Figure 2.
The pellets from MK were subjected to a refined microstructural and mineralogical analysis.
SEM-EDS analyses (Figure 3) showed that the X30Y15 sample constituted a fairly homogeneous porous
matrix with a dominating content of Ca and Si, but also included Zn, Sr, and Mg (spectrum 1 in
Figure 3). Such experimental evidence indicates a successful incorporation of the elements in the solid
solution (B was not detectable by EDS analysis). However, some portions with different chemical
composition, i.e., with a darker colour in the backscattered electron image, were detected. The Ca/Si
ratio in these portions presented significant variations, passing from high levels (spectra 2–3), typically
presented by wollastonite (CaSiO3, i.e., Ca/Si = 1), to particularly low levels, corresponding to almost
pure silica (spectrum 4). Such experimental data indicate that the reaction process still did not lead to a
full incorporation of all the chemical constituents into a single crystalline phase; however, hardystonite
solid solution was largely dominant.
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The mean oxide composition of the hardystonite solid solution, reported in Table 3, may
be summarised by the crystal chemical formula of (Ca0.70Sr0.30)2(Zn0.72Mg0.15Si0.13) (Si0.85B0.15)2O7.
This formula was confirmed by the Rietveld refinements, illustrated in Figure 4, performed on a
high-resolution diffraction pattern (14 h data collection, Co anode instead of Cu anode used for
preliminary phase identification studies).
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Figure 4. Rietveld refine ent of X30Y15.
The chemical formula of hardystonite from EMP-WSD analysis was implemented in a melilite
structural model Panalytical ICSD database (akermanite 280405). Atomic positions and occupancies
were refined (see Table 4) with the exception of the 2a Wyckoff position, including 3 atomic species
(Si, Zn, Mg). The Rietveld refinement led to an excellent fitting of experimental data and evidenced
secondary phases, in the forms of pseudo-wollastonite, wollastonite 2M, and quartz, in limited amounts
(not exceeding 7 wt%). The presence of pseudo-wollastonite was also confirmed by the characteristic
cathodo-luminescence [35] observed during EMP-WDS analysis.
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Table 4. Detail of atomic positions and occupancies of the main crystal phase.
ATOM WYCKOFF S.O.F. X Y Z Biso
O1 8f 1.000000 0.3145(2) 0.5777(1) 0.2073(2) 0.500000
O2 4e 1.000000 0.1401(2) 0.6401(2) 0.7461(2) 0.500000
O3 2c 1.000000 0.000000 0.500000 0.1607(4) 0.500000
Si1 2a 0.130000 0.000000 0.000000 0.000000 0.500000
Zn 2a 0.718765 0.000000 0.000000 0.000000 0.500000
Mg 2a 0.150000 0.000000 0.000000 0.000000 0.500000
Sr 4e 0.2995(8) 0.666(8) 0.166(8) 0.4943(2) 0.500000
Ca 4e 0.7005(8) 0.666(8) 0.166(8) 0.494200 0.500000
B 8f 0.150(2) 0.141(3) 0.639(3) 0.0592(1) 0.500000
Si2 8f 0.850(2) 0.141(3) 0.639(3) 0.0592(1) 0.500000
3.2. Obtainment of Scaffolds and Foams
Scaffolds and foams were prepared starting from MK- and H62C-based mixtures, respectively.
Figure 5 shows selected images from scaffolds based on the X30Y15 formulation from direct ink writing
of silicone pastes. Owing to the use of anhydrous borate, the residual porosity was quite limited;
however, some microcracks were still visible (Figure 5a,b). These cracks are ascribable to the gas
released from fillers and from the ceramic transformation of the MK silicone (still representing the
dominant silica source). The filaments, in any case, showed a good interpenetration (Figure 5b); high
magnification details (Figure 5c) showed the formation of a multitude of tiny crystals. The scaffolds,
in terms of strength (Table 3) for both settings of filament spacing (800 and 1600 µm), compared
favourably with other hardystonite scaffolds with similar porosity [36].
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Figure 5. Microstructural details of highly porous ceramics based on hardystonite solid solution, after
firing at 950 ◦C; (a–c) printed scaffolds; (d–f) Foams.
The water vapour released from within H62C still in its polymer state, from the use of hydrated
fillers (hydrated Ca borate and Mg(OH)2), led to a very remarkable foa ing at 420 ◦C. The
ceramic transform ti n confirmed an abun ant porosity (>80 vol%), completely open and with
wide intercon ections (>100 µm), reflecting the main requirements f a scaffold for tissue engineering
applications [37], as shown in Figure 5d. The high magnificati n det ils illustrate the presence of
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a substantial porosity in the cell walls (Figure 5e,f), resulting from the gas released upon ceramic
conversion, as well as the macro-porosity determined by the low temperature foaming, caused by
dehydration of some fillers. Porous walls are known to promote cell adhesion, absorption of metabolites,
and faster controlled rates for the release of ionic dissolution products [38]. The observed crushing
strength (Table 5) is in the order of that of silicate foams with the same porosity [14,39].
Table 5. Physical and mechanical properties of cellular Sr/Mg-doped hardystonite ceramics.
Sample Type - Bulk Density(g/cm3)
Total Porosity
(vol%)
Open Porosity
(vol%)
Compressive Strength
(MPa)
Scaffolds
800 * 1.38 ± 0.01 56 ± 2 56 ± 2 4.6 ± 0.5
1600 * 0.90 ± 0.05 71 ± 1 71 ± 1 1.6 ± 0.2
Foams - 0.60 ± 0.02 82 ± 1 82 ± 1 1.5 ± 0.2
* Spacing between filaments (µm).
3.3. Preliminary Cell Tests
The phase assemblage, resulting from the mineralogical analysis, supports the hypothesis of a
crystallinity degree not exceeding 80 wt%, as seen in the relatively high content of MgO detected
in the hardystonite solid solution (corresponding to 93% of the crystals), compared to the reference
stoichiometry (X30Y15). This estimation is consistent with the assumption of MgO completely
embedded in the hardystonite solution and the other oxides being distributed, except for minor crystal
phases, in a glass phase surrounding the silicate crystals. This implies, above all, that the concentration
of B2O3 (in an amount of about 30 wt% of the glassy phase) could be critical for the application of the
developed porous materials in tissue engineering. In fact, although present in many bioceramics [29,30],
B2O3 is quite controversial because of the potential toxicity of boron released in solution as borate ions
(BO3)3− [40,41].
Preliminary cell tests were performed on X30Y15 scaffolds with the specific purpose of elucidating
any cytotoxic effect. The cell viability of ST2 cells in the presence of the scaffold eluates is shown
in Figure 6. The reference, which relates to cells cultured only with CCM, was normalised to 100%.
Quantitative assessment after 48 h of culture shows that there was an increase in cell viability with a
decrease in the concentration of the scaffold eluates in the cell culture medium. In the case of 0.01%
dilution, the highest cell viability was achieved by the 0.1% concentration. The values are statistically
relevant as the difference was greater than p = 0.001. The scaffold eluates were found to not be cytotoxic
after 48 h of incubation in contact with bone marrow stromal cells.
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statistical analysis denotes significant difference (** p < 0.0 1; * p < 0.05).
In Figure 7, the VEGF released from the ST2 cel s cultured in CCM with different dilutions (1%,
0.1%, and 0.01 ) f ff . Measuring the increase in VEGF concentration when cells
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are exposed to dissolution products of biomaterials is a suitable in vitro methodology [42] to assess
the potential angiogenic effect of the material being investigated, given that increased VEGF will
attract endothelial cells, being thus a marker for the vascularisation potential of the biomaterial. The
eluates of this scaffold increased VEGF secretion with increasing supernatant concentration. The 1%
supernatant sample showed the highest release of VEGF for all three dilutions. These results were also
in accordance with the data obtained from the cell viability study. However, the results also indicated
no significant variation as a function of the reference sample.
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one-way ANOVA statistical analysis denotes significant difference (*** p < 0.001).
Representative light microscope images of bone marrow stromal ST-2 cells (H&E stained), treated
with the supernatant of the scaffold at different concentrations (0.01–1 of scaffold) after 48 h of
incubation, are shown in Figure 8. The images demonstrate clearly that ST-2 cells grew in contact with
the supernatant without any appreciable change in cell morphology. A dense formed cell layer in
contact with all sample supernatants was observed.
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B3+ ions modifying the ZnSi2O74− sheets, and Sr2+ ions partially replacing the Ca2+ ions sandwiched
between the same sheets.
The use of silicones mixed with fillers, besides favouring synthesis, enabled the application
of simple shaping technologies, such as direct ink writing and direct foaming, at low temperature,
with silicones still in the polymer state. All developed porous hardystonite ceramics compared well,
in terms of strength-to-density ratio, with the analogous materials presented in the literature. The
direct foaming, in particular, is promising for the possibility of obtaining cellular bodies with both
well-interconnected macropores and porous cell walls. According to the results of preliminary cell
tests, the developed ceramics were not cytotoxic.
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